6Ashish KJ,Gilad JK,Eve R, et al. Identifying hospital admissions due to adverse drug events using a computer-based momtor.Pharmacoepidemiology and Drug Safety , 2001.10:113-119.
7Peachey J, From Pharmacovigilance to Pharmacoperformance. Drug Safety, 2002,259(6) :399-405.
8Arlett PR, Harrison P. Compliance in European pharmacovilance: a regulatory view. Pharmacoepidemiology and Drug Safety, 2001,10:301-302.
9Grootheest ACV, Puijenbroek EPV, Jong LTD. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiology and Drug Safety, 2002, 11 :205-210.
10Lumley CE, Walker SR,Hall GC, et al. The under-reporting of adverr, e reactions in general practice, Pharm Med,1986,1 : 205-212.
